Zio AT ECG Monitoring System vs eMurmur Heart AI
AI Verdict
Choose Zio AT ECG Monitoring System if…
Choose Zio AT if your primary need is continuous, long-term ECG monitoring to detect and characterize intermittent or asymptomatic cardiac arrhythmias over an extended period. This system is ideal for patients experiencing symptoms suggestive of arrhythmias that are not captured by shorter-duration monitoring, providing up to 14 days of uninterrupted ECG data for comprehensive diagnostic insights.
View Zio AT ECG Monitoring System →Choose eMurmur Heart AI if…
Choose eMurmur Heart AI if you require an AI-powered solution for automated analysis of heart and lung sounds to screen for murmurs and other auscultatory abnormalities. This tool is particularly well-suited for augmenting physical examinations in telehealth, primary care, or remote monitoring settings, enabling quick identification of potential cardiac or pulmonary issues through digital stethoscope integration and comparative data analysis.
View eMurmur Heart AI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Zio AT ECG Monitoring System | eMurmur Heart AI |
|---|---|---|
| Pricing | Contact for pricing | Contact for quote |
| Deployment | Cloud-based (data analytics and clinician portal) | Web-based, Mobile App, API integration |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Zio AT ECG Monitoring SystemThe Zio AT system offers superior patient usability due to its wearable patch for continuous, passive monitoring, requiring minimal patient interaction during the wear period. This 'set it and forget it' approach for up to 14 days simplifies the patient experience compared to eMurmur Heart AI, which necessitates active clinician auscultation with a digital stethoscope.
Clinical Value
Zio AT ECG Monitoring SystemWhile both tools offer significant clinical value in their respective domains, Zio AT's continuous, long-term ECG monitoring for up to 14 days provides a critical advantage in detecting often intermittent and elusive cardiac arrhythmias, including asymptomatic events. This extended monitoring period can lead to a more comprehensive diagnosis of rhythm disorders compared to the point-in-time auscultation provided by eMurmur Heart AI.
Pricing & Value
TieNeither tool publicly discloses its pricing details, making a direct comparison of their cost-effectiveness and overall value impossible. Both require contacting the company for specific pricing information, which is a common practice for specialized medical devices and services.
Enterprise Readiness
TieBoth Zio AT and eMurmur Heart AI demonstrate strong enterprise readiness, being FDA-cleared, HIPAA compliant, and offering Business Associate Agreements (BAAs). Their cloud-based deployment models, along with support for EHR integration and web/mobile access, ensure they can be seamlessly integrated into various healthcare IT environments.
Innovation
Zio AT ECG Monitoring SystemZio AT exhibits a slightly higher degree of innovation through its integrated system of a wearable patch for continuous, long-term ECG recording, wireless data transmission, and an FDA-cleared deep-learned AI algorithm for comprehensive arrhythmia detection. This end-to-end, passive monitoring solution for extended periods represents a significant advancement in capturing elusive cardiac events.
Support & Docs
Zio AT ECG Monitoring SystemiRhythm Technologies, the company behind Zio AT, provides a more extensive and clearly articulated support infrastructure, including dedicated online resources for providers and patients, FAQs, clinical manuals, and a direct customer service line. In contrast, eMurmur Heart AI's publicly available support information primarily points to a general feedback email, suggesting less comprehensive structured documentation and support channels.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Zio AT ECG Monitoring System | eMurmur Heart AI |
|---|---|---|
| Name | Zio AT ECG Monitoring System | eMurmur Heart AI |
| Company | iRhythm Technologies, Inc. | CSD Labs |
| Primary Function | Wearable mobile cardiac telemetry (MCT) for continuous ECG monitoring and arrhythmia detection | AI-powered software for automated analysis of heart and lung sounds, detecting murmurs and providing hemodynamic insights |
| Data Monitored/Analyzed | Continuous ECG recording for arrhythmia detection | Heart and lung sounds (S1, S2, murmurs, crackles, wheezes) |
| AI Application | FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection | AI-powered software platform for automated analysis of heart and lung sounds |
| Supported Specialties | Cardiology | Cardiology, Internal Medicine, Pulmonology |
| Hardware Requirement/Compatibility | Wearable Zio AT patch, Wireless gateway | Hardware-neutral and stethoscope agnostic platform compatibility |
Videos
Demos, reviews, and walkthroughs featuring Zio AT ECG Monitoring System and eMurmur Heart AI.
Frequently Asked Questions
More Comparisons
More matchups featuring Zio AT ECG Monitoring System or eMurmur Heart AI
Backers
Who funded each tool's parent company.